Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende Patientenratgeber
Erweiterte Suche
Anmelden
nach oben
Archives of Dermatological Research
Erschienen in:

06.11.2019 | Review

DNA methylation and inflammatory skin diseases

verfasst von: Joshua S. Mervis, Jean S. McGee

Erschienen in: Archives of Dermatological Research | Ausgabe 7/2020

Einloggen, um Zugang zu erhalten

Abstract

Epigenetics is the study of heritable changes in gene expression that do not originate from alternations in the DNA sequence. Epigenetic modifications include DNA methylation, histone modification, and gene silencing via the action of microRNAs. Epigenetic dysregulation has been implicated in many disease processes. In the field of dermatology, epigenetic regulation has been extensively explored as a pathologic mechanism in cutaneous T-cell lymphoma (CTCL), which has led to the successful development of epigenetic therapies for CTCL. In recent years, the potential role of epigenetic regulation in the pathogeneses of inflammatory skin diseases has gained greater appreciation. In particular, epigenetic changes in psoriasis and atopic dermatitis have been increasingly studied, with DNA methylation the most rigorously investigated to date. In this review, we provide an overview of DNA methylation in inflammatory skin diseases with an emphasis on psoriasis and atopic dermatitis.
Literatur
1.
Waddington CH (2012) The epigenotype. Int J Epidemiol 41(1):10–13PubMed
2.
Rodríguez-Paredes M, Esteller M (2011) Cancer epigenetics reaches mainstream oncology. Nat Med 17(3):330–339PubMed
3.
Berger SL, Kouzarides T, Shiekhattar R et al (2009) An operational definition of epigenetics. Genes Dev 23(7):781–783PubMedPubMedCentral
4.
Feinberg AP, Koldobskiy MA, Göndör A (2016) Epigenetic modulators, modifiers and mediators in cancer aetiology and progression. Nat Rev Genet 17(5):284–299PubMedPubMedCentral
5.
Dawson MA, Kouzarides T (2012) Cancer epigenetics: from mechanism to therapy. Cell 150(1):12–27PubMed
6.
Wu X, Zhang Y (2017) TET-mediated active DNA demethylation: mechanism, function and beyond. Nat Rev Genet 18(9):517–534PubMed
7.
Esteller M (2007) Cancer epigenomics: DNA methylomes and histone-modification maps. Nat Rev Genet 8(4):286–298PubMed
8.
Feinberg (2018) The key role of epigenetics in human disease. N Engl J Med 379(4):400–401PubMed
9.
Li Y, Sawalha AH, Lu Q (2009) Aberrant DNA methylation in skin diseases. J Dermatol Sci 54(3):143–149PubMed
10.
Shanmugam MK, Sethi G (2013) Role of epigenetics in inflammation-associated diseases. Subcell Biochem 61:627–657PubMed
11.
Jeltsch A, Jurkowska RZ (2014) New concepts in DNA methylation. Trends Biochem Sci 39(7):310–318PubMed
12.
Robertson KD (2005) DNA methylation and human disease. Nat Rev Genet 6(8):597–610PubMed
13.
Boehncke WH, Schön MP (2015) Psoriasis. Lancet 386:983–994PubMed
14.
Grozdev I, Korman N, Tsankov N (2014) Psoriasis as a systemic disease. Clin Dermatol 32(3):343–350PubMed
15.
Gladman DD, Antoni C, Mease P et al (2005) Psoriatic arthritis: epidemiology, clinical features, course, and outcome. Ann Rheum Dis 64(Suppl 2:ii1):4–7
16.
Lu Q (2013) The critical importance of epigenetics in autoimmunity. J Autoimmun 41:1–5PubMed
17.
Wang Z, Long H, Chang C, Zhao M, Lu Q (2018) Crosstalk between metabolism and epigenetic modifications in autoimmune diseases: a comprehensive overview. Cell Mol Life Sci 75(18):3353–3369PubMed
18.
Zhao M, Lu Q (2018) The aberrant epigenetic modifications in the pathogenesis of psoriasis. J Investig Dermatol Symp Proc 19(2):S81–S82.PubMed
19.
Pollock RA, Abji F, Gladman DD (2017) Epigenetics of psoriatic disease: A systematic review and critical appraisal. J Autoimmun. 78:29–38PubMed
20.
Traupe H, van Gurp PJ, Happle R et al (1992) Psoriasis vulgaris, fetal growth, and genomic imprinting. Am J Med Genet 42(5):649–654PubMed
21.
Generali E, Ceribelli A, Stazi MA et al (2017) Lessons learned from twins in autoimmune and chronic inflammatory diseases. J Autoimmun 83:51–61PubMed
22.
Xiang Z, Yang Y, Chang C, Lu Q (2017) The epigenetic mechanism for discordance of autoimmunity in monozygotic twins. J Autoimmun 1(83):43–50
23.
Zhang P, Su Y, Chen H et al (2010) Abnormal DNA methylation in skin lesions and PBMCs of patients with psoriasis vulgaris. J Dermatol Sci 60(1):40–42PubMed
24.
Yooyongsatit S, Ruchusatsawat K, Noppakun N et al (2015) Patterns and functional roles of LINE-1 and Alu methylation in the keratinocyte from patients with psoriasis vulgaris. J Hum Genet 60(7):349–355PubMed
25.
Murata Y, Bundo M, Ueda J et al (2017) DNA methylation and hydroxymethylation analyses of the active LINE-1 subfamilies in mice. Sci Rep 7(1):13624PubMedPubMedCentral
26.
Roberson ED, Liu Y, Ryan C et al (2012) A subset of methylated CpG sites differentiate psoriatic from normal skin. J Invest Dermatol. 132(3):583–592PubMed
27.
Verma D, Ekman AK, Bivik Eding C et al (2018) Genome-wide DNA methylation profiling identifies differential methylation in uninvolved psoriatic epidermis. J Invest Dermatol 138(5):1088–1093PubMed
28.
Zhang P, Zhao M, Liang G et al (2013) Whole-genome DNA methylation in skin lesions from patients with psoriasis vulgaris. J Autoimmun 41:17–24PubMed
29.
Zhou F, Wang W, Shen C et al (2016) Epigenome-wide association analysis identified nine skin DNA methylation loci for psoriasis. J Invest Dermatol 136(4):779–787PubMed
30.
Tang L, Cheng Y, Zhu C et al (2018) Integrative methylome and transcriptome analysis to dissect key biological pathways for psoriasis in Chinese Han population. J Dermatol Sci 91(3):285–291PubMed
31.
Chen M, Chen ZQ, Cui PG et al (2008) The methylation pattern of p16INK4a gene promoter in psoriatic epidermis and its clinical significance. Br J Dermatol 158(5):987–993PubMed
32.
Chen M, Wang Y, Yao X et al (2016) Hypermethylation of HLA-C may be an epigenetic marker in psoriasis. J Dermatol Sci. 83(1):10–16PubMed
33.
Chandra A, Senapati S, Roy S et al (2018) Epigenome-wide DNA methylation regulates cardinal pathological features of psoriasis. Clin Epigenetics 10(1):108PubMedPubMedCentral
34.
Gervin K, Vigeland MD, Mattingsdal M et al (2012) DNA methylation and gene expression changes in monozygotic twins discordant for psoriasis: identification of epigenetically dysregulated genes. PLoS Genet 8(1):e1002454PubMedPubMedCentral
35.
Han J, Park SG, Bae JB et al (2012) The characteristics of genome-wide DNA methylation in naïve CD4+ T cells of patients with psoriasis or atopic dermatitis. Biochem Biophys Res Commun 422(1):157–163PubMed
36.
Park GT, Han J, Park SG et al (2014) DNA methylation analysis of CD4+ T cells in patients with psoriasis. Arch Dermatol Res. 306(3):259–268PubMed
37.
Gu X, Nylander E, Coates PJ et al (2015) Correlation between reversal of DNA methylation and clinical symptoms in psoriatic epidermis following narrow-band UVB phototherapy. J Invest Dermatol 135(8):2077–2083PubMedPubMedCentral
38.
Bieber T (2008) Atopic dermatitis. N Engl J Med 358(14):1483–1494PubMed
39.
Liang Y, Chang C, Lu Q (2016) The genetics and epigenetics of atopic dermatitis—filaggrin and other polymorphisms. Clin Rev Allergy Immunol 51(3):315–328PubMed
40.
Lockett GA, Soto-Ramírez N, Ray MA et al (2016) Association of season of birth with DNA methylation and allergic disease. Allergy 71(9):1314–1324PubMed
41.
Wang IJ, Chen SL, Lu TP et al (2013) Prenatal smoke exposure, DNA methylation, and childhood atopic dermatitis. Clin Exp Allergy 43(5):535–543PubMed
42.
Nguyen CM, Liao W (2015) Genomic imprinting in psoriasis and atopic dermatitis: a review. J Dermatol Sci 80(2):89–93PubMedPubMedCentral
43.
Nakamura T, Sekigawa I, Ogasawara H et al (2006) Expression of DNMT-1 in patients with atopic dermatitis. Arch Dermatol Res 298(5):253–256PubMed
44.
Novak N, Bieber T, Leung DY (2003) Immune mechanisms leading to atopic dermatitis. J Allergy Clin Immunol. 112(6 Suppl):S128–S139PubMed
45.
Luo Y, Zhou B, Zhao M et al (2014) Promoter demethylation contributes to TSLP overexpression in skin lesions of patients with atopic dermatitis. Clin Exp Dermatol 39(1):48–53PubMed
46.
Ziyab AH, Karmaus W, Holloway JW et al (2013) DNA methylation of the filaggrin gene adds to the risk of eczema associated with loss-of-function variants. J Eur Acad Dermatol Venereol 27(3):e420–e423PubMed
47.
Rodríguez E, Baurecht H, Wahn AF et al (2014) An integrated epigenetic and transcriptomic analysis reveals distinct tissue-specific patterns of DNA methylation associated with atopic dermatitis. J Invest Dermatol 134(7):1873–1883PubMed
48.
Leoni C, Montagner S, Rinaldi A et al (2017) DNMT3a restrains mast cell inflammatory responses. Proc Natl Acad Sci USA 114(8):E1490–E1499PubMedPubMedCentral
49.
Leoni C, Montagner S, Deho' L et al (2015) Reduced DNA methylation and hydroxymethylation in patients with systemic mastocytosis. Eur J Haematol 95(6):566–575PubMed
50.
Shukla A, Sehgal M, Singh TR (2015) Hydroxymethylation and its potential implication in DNA repair system: a review and future perspectives. Gene 564(2):109–118PubMed
51.
Hessam S, Sand M, Lang K et al (2017) Altered global 5-hydroxymethylation status in hidradenitis suppurativa: support for an epigenetic background. Dermatology 233(2–3):129–135PubMed
52.
Cruz AF, de Resende RG, de Lacerda JCT et al (2018) DNA methylation patterns of genes related to immune response in the different clinical forms of oral lichen planus. J Oral Pathol Med. 47(1):91–95PubMed
53.
Mervis JS, McGee JS (2019) Epigenetic therapy and dermatologic disease: moving beyond CTCL. J Dermatolog Treat 30(1):68–73PubMed
Metadaten
Titel
DNA methylation and inflammatory skin diseases
verfasst von
Joshua S. Mervis
Jean S. McGee
Publikationsdatum
06.11.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
Archives of Dermatological Research / Ausgabe 7/2020
Print ISSN: 0340-3696
Elektronische ISSN: 1432-069X
DOI
https://doi.org/10.1007/s00403-019-02005-9

Weitere Artikel der Ausgabe 7/2020

Nasolabial fold correction through cheek volume loss restoration versus thread lifting: a comparative study

  • Original Paper

Effects of tumor necrosis factor-like ligand 1A (TL1A) on imiquimod-induced psoriasiform skin inflammation in mice

  • Original Paper

Hidradenitis suppurativa and pemphigus: a cross-sectional study

  • Original Paper

Molecular profiling of TOX-deficient neoplastic cells in cutaneous T cell lymphoma

  • Open Access
  • Concise Communication

Epicardial fat thickness is ıncreased and associated with disease severity in hidradenitis suppurativa

  • Original Paper

Surgical site infections after microscopically controlled skin surgery in immunocompromised patients: a retrospective two-center cohort study

  • Original Paper

Kompaktes Leitlinien-Wissen Dermatologie (Link öffnet in neuem Fenster)

Mit medbee Pocketcards schnell und sicher entscheiden.
Leitlinien-Wissen kostenlos und immer griffbereit auf ihrem Desktop, Handy oder Tablet.

Kostenlos registrieren

Neu im Fachgebiet Dermatologie

Alopezie: Dosisreduktion von Baricitinib auf dem Prüfstand

Wenn die Behandlung mit Baricitinib bei Alopecia areata nach 52 Wochen klinisch anspricht, kann die Dosis unter Umständen reduziert werden. Dies legen zumindest die Ergebnisse einer Substudie von BRAVE-AA2 nahe.

Wie gefährlich sind suspekte Veränderungen in der Mundhöhle?

Wie hoch ist das Risiko, dass sich aus einer bereits verdächtigen Veränderung der Mundschleimhaut ein Karzinom entwickelt? Ein US-Team hat dazu das Patientenregister der Universität San Francisco ausgewertet.

Chronische Rhinitis mit Botox lindern

Eine Injektion von Botulinumtoxin A in die Nasenmuscheln lindert Beschwerden einer chronischen Rhinitis für etwa zwei bis drei Monate. Vor allem Personen mit allergischer Rhinitis können davon profitieren.

Neue Creme gegen Melasmen

Eine Creme mit Alpha-Arbutin und Kojisäure hat sich in einer neuen Studie als wirksam zur Therapie von Melasmen erwiesen. Sie war ebenso effektiv wie eine Triple-Combination-Creme, es traten aber weniger Rezidive und Nebenwirkungen auf.

Update Dermatologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise